Korro Bio (KRRO) Cash from Financing Activities (2018 - 2026)
Korro Bio (KRRO) reported Cash from Financing Activities of -$2.92 million for Q2 2026, compared with $5,000 a year earlier.
Korro Bio (KRRO) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Korro Bio's Cash from Financing Activities came in at $85.8 million; for FY2025, it came in at $685,000, down 99.0% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of -58.7% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $69.36 million in FY2024 (-63.1%), $187.76 million in FY2023, $18,000 in FY2022 (-98.7%) and $1.36 million in FY2021 (-97.6%).
- The Q2 2026 figure ranks as the lowest quarterly Cash from Financing Activities in data going back to Q4 2018.
- Year over year, Cash from Financing Activities gained in 1 of the last five quarters, with an average decline of 63.5%.
- The high point for year-over-year Cash from Financing Activities in five years was Q1 2025 (growth of 23.7%); the low point was Q2 2025 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $88.21 million (Q1 2026), $380,000 (Q4 2025) and $128,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Korro Bio | 145.73 Mn | -250.91 Mn | - | -2.92 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.92 Mn |
| Mar 31, 2026 | 88.21 Mn |
| Dec 31, 2025 | 380,000.00 |
| Sep 30, 2025 | 128,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Dec 31, 2024 | 932,000.00 |
| Sep 30, 2024 | 728,000.00 |
| Jun 30, 2024 | 67.56 Mn |
| Mar 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 144.59 Mn |
| Sep 30, 2023 | -2.19 Mn |
| Jun 30, 2023 | -36,000.00 |
| Mar 31, 2023 | 45.40 Mn |
| Dec 31, 2022 | -238,000.00 |
| Sep 30, 2022 | 56,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 109,000.00 |
| Sep 30, 2021 | 349,000.00 |
| Jun 30, 2021 | 328,000.00 |
Korro Bio Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KRRO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();